Anybody around?
It is a solid company with small floats. Plus they have tow products. Anyone has idea of the mechanism of the oral peptide delivery system for erectile dysfunction? Hope it is not through liposome.
Palatin Technologies Holds Annual Meeting
PRINCETON, N.J.--(BW HealthWire)--March 25, 1998--Palatin Technologies (Nasdaq:PLTN
- news) Wednesday announced that it held its Annual Meeting of Stockholders Tuesday, March
24, 1998, at 11 a.m., at the company's headquarters as scheduled.
According to the announcement by Palatin Technologies Chairman President and Chief Executive
Officer Edward J. Quilty, a quorum of stockholders was present in person or by proxy, and all
proposals submitted to the stockholders were approved.
The Directors elected were Edward J. Quilty, 46, chairman, president and chief executive officer
of Palatin Technologies and also chairman of the board of Derma Sciences, a publicly traded
company; Carl Spana, Ph.D., 35, Palatin's executive vice president and chief technology officer;
Michael S. Weiss, 31, general counsel of Paramount Capital Investments and senior managing
director of Paramount Capital Inc.; James T. O'Brien, 58, president and chief executive officer
of O'Brien Marketing and Communications, an advertising and communications company; and
John K.A. Prendergast, Ph.D., 43, president and principal of Summercloud Bay Inc., a
biotechnology consulting firm.
All these directors have double duty, what are they actually doing?
|
